These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9851651)

  • 1. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.
    Mazzini L; Mora G; Balzarini C; Brigatti M; Pirali I; Comazzi F; Pastore E
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S57-63. PubMed ID: 9851651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis.
    Miller RG; Moore DH; Gelinas DF; Dronsky V; Mendoza M; Barohn RJ; Bryan W; Ravits J; Yuen E; Neville H; Ringel S; Bromberg M; Petajan J; Amato AA; Jackson C; Johnson W; Mandler R; Bosch P; Smith B; Graves M; Ross M; Sorenson EJ; Kelkar P; Parry G; Olney R;
    Neurology; 2001 Apr; 56(7):843-8. PubMed ID: 11294919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group.
    Miller RG; Moore D; Young LA; Armon C; Barohn RJ; Bromberg MB; Bryan WW; Gelinas DF; Mendoza MC; Neville HE; Parry GJ; Petajan JH; Ravits JM; Ringel SP; Ross MA
    Neurology; 1996 Dec; 47(6):1383-8. PubMed ID: 8960715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
    Welty DF; Schielke GP; Rothstein JD
    Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS defeats gabapentin: reflections on another failed treatment.
    McDermott MP; Rowland LP
    Neurology; 2001 Apr; 56(7):826-7. PubMed ID: 11294916
    [No Abstract]   [Full Text] [Related]  

  • 6. ALS defeats gabapentin: reflections on another failed treatment.
    Brigell MG; Taylor CP
    Neurology; 2001 Oct; 57(8):1524-5. PubMed ID: 11673613
    [No Abstract]   [Full Text] [Related]  

  • 7. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.
    Kalra S; Cashman NR; Caramanos Z; Genge A; Arnold DL
    AJNR Am J Neuroradiol; 2003 Mar; 24(3):476-80. PubMed ID: 12637300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
    Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
    Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of fasciculations in patients with amyotrophic lateral sclerosis with the use of gabapentin.
    Romano JG
    Arch Neurol; 1996 Aug; 53(8):716. PubMed ID: 8759976
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of gabapentin and lamotrigine.
    Cory PR; Gidal Be
    Ann Pharmacother; 1995 Nov; 29(11):1160-1. PubMed ID: 8573963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of orthostatic tremor with gabapentin.
    Evidente VG; Adler CH; Caviness JN; Gwinn KA
    Mov Disord; 1998 Sep; 13(5):829-31. PubMed ID: 9756154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.
    Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH
    Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic reversal of cortical hyperexcitability in patients with ALS.
    Caramia MD; Palmieri MG; Desiato MT; Iani C; Scalise A; Telera S; Bernardi G
    Neurology; 2000 Jan; 54(1):58-64. PubMed ID: 10636126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
    Muscas GC; Chiroli S; Luceri F; Mastio MD; Balestrieri F; Arnetoli G
    Seizure; 2000 Jan; 9(1):47-50. PubMed ID: 10667963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin in partial epilepsy. UK Gabapentin Study Group.
    Lancet; 1990 May; 335(8698):1114-7. PubMed ID: 1971862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?
    Armon C
    Amyotroph Lateral Scler Other Motor Neuron Disord; 1999 Dec; 1(1):3-14. PubMed ID: 12365066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.
    Mazzini L; Testa D; Balzarini C; Mora G
    J Neurol; 1994 Feb; 241(4):223-7. PubMed ID: 8195821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Meininger V
    Lancet; 1996 May; 347(9013):1425-31. PubMed ID: 8676624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.